XML 40 R29.htm IDEA: XBRL DOCUMENT v3.19.1
NOTE 11 - SHARE-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2018
Note 11 - Share-based Compensation  
Impact on operations of recording share-based compensation
    Year Ended December  31,
    2018   2017
 (in thousands)        
Cost of goods sold   $25   $18
Research and development   266   164
Selling, general and administrative   939   532
Total share-based compensation   $1,230   $714
         
Fair value of share-based awards for employee stock options
    Employee Stock
    Options
    2018   2017
         
Risk-free interest rates   N/A   1.72%
Volatility factors   N/A   62.00%
Expected life of the option in years   N/A   4.0
Expected dividend yield   N/A   None
Stock option grants
    2018   2017
    Options   Weighted-Average Exercise Price   Weighted-Average Remaining Contractual Life in Years   Options   Weighted-Average Exercise Price   Weighted-Average Remaining Contractual Life in Years
                         
Outstanding at beginning of year   40,000   $6.10       376,000   $2.95    
Granted   -   -       25,000   8.03    
Exercised   (15,000)   2.83       (346,000)   2.83    
Cancelled, Expired or                        
Forfeited   -   -       (15,000)   6.01    
Outstanding at end of year   25,000   $8.03   4.50   40,000   $6.10   3.60
                         
Vested or expected to vest at the end of the period   22,924   $8.03   4.50   34,460   $5.79   3.29
Exercisable at end of year   7,813   $8.03   4.50   16,563   $3.37   0.91
Restricted stock award including performance-based stock award activity under our share-based compensation plan
                 
    2018   2017
    Awards   Weighted - Average Grant Date Fair Value   Awards   Weighted - Average Grant Date Fair Value
Outstanding at beginning of year   565,850   $5.09   464,850   $2.78
   Granted   206,856   7.11   287,600   7.29
   Vested   (213,100)   4.51   (181,725)   2.72
   Cancelled   (750)   4.24   (4,875)   3.06
Outstanding at end of year   558,856   $6.06   565,850   $5.09
                 
Unvested options grants and restricted stock awards
    December 31,
2018
  December 31,
2017
         
Unamortized future compensation expense   $2,835,978   $2,560,844
Remaining weighted average amortization period in years   2.63   2.98